| Position | Action |
|---|---|
| Single confirmation signal with successful $478 retest on declining volume | Add 10-15% tactical position |
| 2+ signals confirm simultaneously | Add second 10-15% tranche (max 25% total tactical adds) |
| Weekly close below $472.91 | Cut position by 50%, reassess immediately |
| Bounce into $504-508 zone stalls on declining volume with bearish MACD/RSI divergence | Trim 25% into strength |
| Q3 2026 earnings miss or FCF below $0.85B with capex above $1.4B | Trim further |
The post-earnings sell-off is a mispriced gift: record $8.1B backlog, semiconductor gas secular growth, and a 200 SMA support test that has held twice, creating asymmetric risk/reward toward the $504-512 zone in a stock returning 4% of market cap annually.
| Indicator | Value | Signal |
|---|---|---|
| 10 EMA | 494.49 | bearish |
| 50 SMA | 511.83 | bearish |
| 200 SMA | 472.91 | bullish |
| MACD | −8.05 (hist −2.10) | bearish |
| RSI (14) | 39.47 | neutral |
| Bollinger Middle Band (20 SMA) | 504.58 | neutral |
| Bollinger Lower Band | 476.88 | neutral |
| ATR (14) | 11.48 | neutral |
| Latest Close | 489.98 | neutral |
| Gap-down Low (7/31) | 466.88 | bearish |
Support: 466.88 · 472.91 · 476.41 · 478 · 480 · 485 | Resistance: 489 · 494.49 · 494.73 · 504.58 · 505 · 511.83 · 512 · 520 · 546.64
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
Hold LIN with tactical add framework; $472.91 weekly close is the structural invalidation level
The HOLD verdict balances three converging factors: (1) Undisputed fundamental quality with $8.1B backlog, 11.3% EPS growth, and structurally accelerating chip gas thesis; (2) Real technical damage with MACD at -8.05 accelerating lower, descending 50 SMA, and institutional distribution on 7/31; (3) Valuation asymmetry with 31.6x P/E (50% premium to industrial gas norms) and 2.09x PEG (double sector range). The 200 SMA at $472.91 has held twice on closing basis and is the structural stop; a weekly close below confirms long-term trend break and triggers reassessment toward Underweight. The 10-15% add framework on single confirmation with $478 retest provides bounded asymmetric exposure toward $504-512 while preserving hard invalidation at $472.91.
When: 2+ technical/fundamental signals confirm simultaneously
Then: Second 10-15% tranche available
· concedes: The 50 SMA is sloping down, the MACD is below zero, and momentum is damaged; P/E of 31.6x is full on a static basis; LinCare headwinds are acknowledged (5% segment drag)
LIN is a broken technical setup with deteriorating cash flow, excessive valuation relative to sector peers, and asymmetric downside risk that makes SELL the appropriate recommendation despite quality fundamentals.
· concedes: Quality fundamentals are great; The underlying business is high quality; Record backlog exists
→ vs conservative: Valuation argument of 31.6x P/E and 2.09x PEG is backwards—the multiples have already compressed during the 10% drawdown, making this the entry point rather than the obstacle; the valuation case was stronger at $546
→ vs conservative: FCF concern misreads the data: Q2 FCF down 12.7% is due to $1 billion AR build (growth signal, not deterioration) while operating cash flow actually increased to $2.27 billion from $2.21 billion; $1.4 billion capex is strategic execution against contracted demand, not speculative spending
→ vs neutral: Wait-for-confirmation framework requiring all four technical signals (RSI divergence, MACD cross, 50 SMA flattening, 10 EMA reclaim) results in buying at $505-$512, which is 3-4.5% higher than current levels with the same stop at $472.91, degrading risk-reward from ~1:2 to ~1:1
→ vs neutral: MACD at -8.05 and descending 50 SMA are lagging indicators at basing points; waiting for MACD to turn means buying the breakout, not the base, missing the easy money
LIN is in a post-capitulation basing phase at the 200-day moving average, with a tactical bounce underway but not yet confirmed. The most likely path over the next 1–2 weeks is a grind back toward $504–$512 (mean reversion), with the $478 level as the line that separates a healthy correction from a trend break. Key support sits at $472.91 (200 SMA) and $478 (daily close threshold); key resistance at $494.49 (10 EMA), $504-505 (Bollinger midline), and $511-513 (50 SMA). A 1× ATR stop below current close ($478.50) and a 2× ATR target to upside ($512.94) offer roughly 1:2 risk/reward. Final transaction proposal: HOLD. Initiating new longs is premature; selling into strength near $504–$512 is more attractive than buying at current levels.
Market Cap
$225.87B
52W High
$548.20
52W Low
$387.78
50-DMA
$513.97
200-DMA
$474.20
Beta
0.726
Dividend Yield
1.31%
P/E (TTM)
31.63
Forward P/E
24.99
PEG
2.09
P/B
5.88
EV/EBITDA
~18.0x
FCF (TTM)
$4.16B
Revenue (TTM)
$35.45B
Gross Margin (TTM)
48.3%
Operating Margin (TTM)
28.1%
Net Margin (TTM)
20.4%
ROE
18.4%
ROA
7.16%
Total Assets
$88.35B
Total Equity
$39.08B
Goodwill
$27.93B
Net Tangible Book Value
-$0.41B
Total Debt
$28.01B
Net Debt
$23.12B
Net Debt / EBITDA
~1.67x
Debt/Equity
68.9%
Current Ratio
0.879
Cash & Equivalents
$4.90B
Treasury Stock
$12.93B
CapEx/Revenue (TTM)
~16%
Operating CF (TTM)
~$12.7B
CapEx (TTM)
~$6.8B
Free Cash Flow (TTM)
$4.16B
Buybacks (TTM)
~$5.17B
Dividends (TTM)
~$2.88B
Total Capital Returned (TTM)
~$8.05B
Q2 2026 Revenue
$9.289B
Q2 2026 EBITDA
$3.57B
Q2 2026 Net Income
$1.928B
Q2 2026 Diluted EPS
$4.15
Q2 2026 Operating CF
$2.271B
Q2 2026 CapEx
$1.438B
Q2 2026 FCF
$0.833B
Q2 2025 Revenue
$8.495B
Q2 2025 Net Income
$1.766B
Q2 2025 Diluted EPS
$3.73
Strengths
Concerns
Linde plc is a globally dominant industrial gases company with a premium valuation justified by its defensive moat, best-in-class margins (28.1% operating, 20.4% net), and strong cash generation ($4.16B TTM FCF). The company delivered record Q2 2026 results with $9.29B revenue (+9.4% YoY) and $4.15 EPS (+11.3% YoY), while returning ~$8.05B to shareholders annually through buybacks and dividends. Key risks include full valuation multiples (P/E 31.63x, PEG 2.09x), high goodwill ($27.93B), and elevated capex requirements for clean energy/electronics projects, while the primary opportunity lies in hydrogen, electronics gases, and healthcare secular growth drivers.